Biolife Solutions (BLFS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,995 | -3,301 | -1,084 | -1,660 | -1,957 |
| Depreciation Amortization | 216 | 271 | 304 | 248 | 172 |
| Accounts receivable | -28 | 108 | -409 | -53 | -208 |
| Accounts payable and accrued liabilities | 194 | -392 | 5 | 459 | 286 |
| Other Working Capital | -796 | -628 | 626 | 1,189 | 558 |
| Other Operating Activity | 435 | 780 | 705 | 671 | 160 |
| Operating Cash Flow | $-4,974 | $-3,162 | $146 | $855 | $-990 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,418 | -585 | -237 | -1,150 | -91 |
| Purchase Of Investment | -1,410 | -7,952 | N/A | N/A | N/A |
| Sale Of Investment | 7,067 | 402 | N/A | N/A | N/A |
| Investing Cash Flow | $4,240 | $-8,135 | $-237 | $-1,150 | $-91 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 475 | 1,095 |
| Common Stock Issued | 369 | 13,680 | 51 | 0 | N/A |
| Financing Cash Flow | $369 | $13,680 | $51 | $475 | $1,095 |
| Beginning Cash Position | 2,539 | 156 | 197 | 17 | 3 |
| End Cash Position | 2,173 | 2,539 | 156 | 197 | 17 |
| Net Cash Flow | $-366 | $2,383 | $-40 | $180 | $14 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,974 | -3,162 | 146 | 855 | -990 |
| Capital Expenditure | -1,418 | -590 | -237 | -1,152 | -94 |
| Free Cash Flow | -6,392 | -3,752 | -91 | -297 | -1,083 |